Cutaneous Hodgkin's disease.
Cutaneous Hodgkin's disease is a rare condition that usually occurs late in the course of Hodgkin's lymphoma. This rare condition is thought to have decreased in incidence in recent decades, likely owing to improved treatment of patients with Hodgkin's disease, who are receiving improved chemotherapy and radiation therapy, and the advent of peripheral blood stem cell transplantation. We present the case of a man who developed specific cutaneous Hodgkin's lymphoma 6 months after nonmyeloablative allogenic stem cell transplantation for his recurrent systemic disease. The patient's manifestation of relapse was cutaneous dissemination of the tumor, manifested by erythematous papules and ulcerated nodules. At the time of the cutaneous relapse he had minimal systemic disease. This case illustrates an example of this complication of Hodgkin's disease and stresses the importance of a timely diagnosis to direct appropriate therapy. A review of the literature demonstrates that the patient's lesion morphology and distribution are typical of specific manifestations of cutaneous Hodgkin's disease.
Introcaso
Camille E
CE
Department of Dermatology, the University of Pennsylvania, Philadelphia, USA.
Kantor
Jonathan
J
Porter
David L
DL
Junkins-Hopkins
Jacqueline M
JM
D000328:Adult; D004890:Erythema / Q000209:etiology / Q000473:pathology; D020350:Graft vs Tumor Effect; D006689:Hodgkin Disease / Q000150:complications* / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D012008:Recurrence; D012878:Skin Neoplasms / Q000473:pathology*; D033581:Stem Cell Transplantation